2020 AAD Annual Meeting

Share on: 
March 20 to March 24, 2020
Colorado Convention Center
Denver, CO
United States

Research coauthored by RTI Health Solutions researchers will be presented at the 2020 AAD Annual Meeting.

Cost-effectiveness for Tildrakizumab and other targeted therapies for the treatment of moderate-to-severe plaque psoriasis in the United States. Jia X, Zhao Y, Zhang J, Carrico J, Brodtkorb TH, Mendelsohn A, Feldman SR, Armstrong A, Wu JJ. 

Related Services:
Conference participants: